Trial Information

Summary: High Grade Prostatic Intraepithelial Neoplasia (PIN), Men Age 30 And Over, 18 Month Oral Medication Research Study

This study is designed to test the safety and efficacy of an investigational oral medication in men with high grade prostatic intraepithelial neoplasia (PIN). PIN is the presence of abnormal tissue in the prostate gland that may lead to cancer of the prostate. The age range is 30 years and over. The study lasts up to 18 months.

For more information,

Contact:

Syd Warner, Clinical Research Coordinator
Sheldon J. Freedman, MD LTD
3061 S. Maryland Parkway, Suite 101
Las Vegas, NV 89109
Telephone: 702-732-0282 ext 256
Fax: 702-369-6981
Email:

Profile Page: Sheldon J. Freedman, MD LTD, Las Vegas, NV

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:44:44 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA